Non-invasive and quantitative evaluation of post-injection muscle damage by pharmacokinetic analysis of creatine kinase release

Veterinary Research

Volumn 27, Issue 4-5, 1996, Pages 343-361

  Lefebvre, H P ^a   Laroute, V ^a   Braun, J P ^a   Lassourd, V ^a   Toutain, P L ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

animal welfare; creatine kinase; local tolerance; muscle damage; pharmacokinetics

Indexed keywords

CREATINE KINASE; DRUG; TISSUE EXTRACT;

ANIMAL WELFARE; ENZYME RELEASE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MUSCLE INJURY; NONHUMAN; PHARMACOKINETICS; REVIEW;

ANIMALIA; BOS TAURUS; CANIS FAMILIARIS; EQUIDAE; ORYCTOLAGUS CUNICULUS; OVIS ARIES;

EID: 0029813160     PISSN: 09284249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Addis PB, Nelson DA, Ma RT, Burroughs JR (1974) Blood enzymes in relation to porcine muscle properties J Anim Sci 38, 279-286
2. Aktas M (1994) Exploration non-invasive des cytolyses musculaires experimentales et spontanées du chien par la créatine kinase. PhD thesis, Institut national polytechnique, Toulouse, France
3. Aktas M, Lefebvre HP, Toutain PL, Braun JP (1995a) Disposition of creatine kinase activity in dog plasma following intravenous and intramuscular injection of skeletal muscle homogenates. J Vet Pharmacol Ther 18, 1-6
4. Aktas M, Vinclair P, Lefebvre HP, Toutain PL, Braun JP (1995 b) In vivo quantification of muscle damage in dogs after intramuscular administration of drugs. Br Vet J 151, 189-196
5. Apple FS, Rhodes M (1988) Enzymatic estimation of skeletal muscle damage by analysis of changes in serum creatine kinase J Appl Physiol 65, 2598-2600
6. Banting A, Tranquart F (1991) Echography as a tool in clinical pharmacology. Acta Vet Scand Suppl 87, 215-216
7. Berrett S, Anderson PH (1983) Changes in plasma creatine kinase activity following storage as whole blood. Vet Rec 113, 321
8. Braun JP, Lefebvre HP, Bezille P, Rico AG, Toutain PL (1995) La créatine kinase chez les bovins : une revue. Rev Med Vet 146, 615-622
9. Brazeau GA, Fung HL (1989) An in vitro model to evaluate muscle damage following intramuscular injections. Pharm Res 6, 167-170
10. Fayolle P, Lefebvre H, Braun JP (1992) Effects of incorrect venepuncture on plasma creatine kinase activity in dog and horse Br Vet J 148, 161-162
11. Friedel R, Bode R, Trautschold I, Mattenheimer H (1976) Verteilung heterologer, homologer und autologer Enzyme nach intravenöser Injektion. Verteilung und Transport von Zellenzymen im extrazellularen Raum III. Mitteilung. J Clin Chem Clin Biochem 14, 129-136
12. Friedel R, Diederichs F, Lindena J (1979) Release of extracellular turnover of cellular enzymes. In: Advances in Clinical Enzymology (E Schmidt, FW Schmidt, I Trautschold, R Friedel, eds), Karger, Basel, 70-105
13. Gibaldi M, Perrier D (1982) Pharmacokinetics, 2nd edition, Marcel Dekker Inc, Basel
14. Hørder M, Elser RC, Gerhardt W, Matthieu M, Sampson EJ (1991) Approved recommendation on IFCC methods for the measurement of catalytic concentration of enzymes. Part 7. IFCC method for creatine kinase (ATP:creatine N-phosphotransferase, EC 2.7 3.2). Eur J Clin Chem Clin Biochem 29, 435-456
15. Houpert P, Serthelon JP, Lefebvre HP, Toutain PL, Braun JP (1995) In vivo non-invasive quantification of muscle damage following a single intramuscular injection of phenylbutazone in sheep Vet Hum Toxicol 37, 105-110
16. Hsu J, Watanabe J (1984) The absolute bioavailability of rabbit muscle creatine phosphokinase after intramuscular administration. Chem Pharm Bull 32, 1922-1928
17. Jones DG (1985) Stability and storage characteristics of enzymes in cattle blood Res Vet Sci 38, 301-306
18. Ladage CA, van Walstijn TA, van Riessen HA (1979) Comparative macroscopic evaluation of muscle damage in rats and in cattle after in tramuscular administration of some commercially available injectable medicines. In: Trends in Veterinary Pharmacology and Toxicology, Proceedings of the 1st European Congress on Veterinary Pharmacology and Toxicology (ASJPAM van Miert, J Frens, FW van der Kreek, eds), Zeist, Elsevier, Amsterdam, 34-40
19. Laska DA, Williams PD, Reboulet JT, Morris RM (1991) The L6 muscle cell line as a tool to evaluate parenteral products for irritation. J Parenter Sci Technol 45, 77-82
20. Lefebvre HP, Jaeg JP, Rico AG, Toutain PL, Braun JP (1992a) Variations of plasma creatine kinase in rabbits following repetitive Wood sampling, effects of pretreatment with acepromazine, carazolol and dantrolene. Eur J Clin Chem Clin Biochem 30, 425-428
21. Lefebvre HP, Rico AG, Toutain PL, Braun JP (1992 b) Détermination de l'activité de la créatine kinase dans les muscles et le plasma du lapin Rev Med Vet 143, 273-275
22. Lefebvre HP, Toutain PL, Bret L, Rico AG, Braun JP (1993a) Compared kinetics of plasma creatine kinase activity in rabbits after intramuscular injection of different preparations of skeletal muscle. Vet Res 24, 468-476
23. Lefebvre HP, Serthelon JP, Ferré JP, de la Farge F, Braun JP (1993 b) Un cas d'intolérance locale après administration intramusculaire d'une formulation retard chez une vache : biologie clinique et échographie. Rev Med Vet 144, 229-233
24. Lefebvre HP (1994) Évaluation quantitative des lésions musculaires iatrogènes par l'analyse pharmacocinétique de la libération de la créatine kinase. Thèse de doctorat d'université, Institut national polytechnique, Toulouse, France
25. Lefebvre HP, Toutain PL, Serthelon JP, Lassourd V, Gardey L, Braun JP (1994) Pharmacokinetic variables and bioavailability from muscle of creatine kinase in cattle. Am J Vet Res 55, 487-493
26. Lindena J, Sommerfeld U, Hopfel C, Wolkersdorfer R, Trautschold I (1983) Enzyme activities in blood cells of man and dogs after separation on a discontinuous Percoll gradient. Enzyme 29, 100-108
27. Lindena J, Trautschold I (1983) Enzymes in lymph: a review J Clin Chem Clin Biochem 21, 327-346
28. Undena J, Sommerfeld U, Höpfel C, Trautschold I (1986) Catalytic enzyme activities concentration in tissues of man, dog, rabbit, guinea pig J Clin Chem Clin Biochem 24, 35-47
29. Mikaelian I, Poul JM, Laurentie M, Sanders P (1994) La créatine phosphokinase (CPK) . un marqueur de la tolérance locale intramusculaire ? In : Les antimicrobiens chez les bovins. Pourquoi et comment choisir ? (J Espinasse, ed), Société française de buiatrie, Paris, 123-124
30. Mordenti J, Green JD (1991) The role of pharmacokinetics and pharmacodynamics in the development of therapeutic proteins. In: New Trends in Pharmacokinetics (A Rescigno, AK Thakur, eds), Plenum Press, New York, 411-424
31. Nouws JFM, Vree TB (1983) Effect of injection site on the bioavailability of an oxytetracycline formulation in ruminant calves. Vet Q 5, 165-170
32. Ohishi H, Tamura S, Shimizu Y, Ikemoto Y (1978) Clinico-biochemical studies of creatine phosphokinase isoenzymes in horses. Res Bull Obihiro Univ 11, 57-74
33. Pyöralä S, Manner L, Kesti E, Sandholm M (1994) Local tissue damage in cows after intramuscular injections of eight antimicrobial agents. Acta Vet Scand 35, 107-110
34. Rasmussen F, Svendsen O (1976) Tissue damage and concentration at the injection site after intramuscular injection of chemotherapeutics and vehicles in pigs. Res Vet Sci 20, 55-60
35. Sobel BE, Markham J, Karlsberg RP, Roberts R (1977) The nature of disapperance of creatine kinase from the circulation and its influence on enzymatic estimation of infarct size. Circ Res 41, 836-844
36. Steiness E, Rasmussen F, Svendsen O, Nielsen P (1978) A comparative study of serum creatine phosphokinase (CPK) activity in rabbits, pigs and humans after intramuscular injection of local damaging drugs. Acta Pharmacol Toxicol 42, 357-364
37. Svendsen O, Rasmussen F, Nielsen P, Steiness E (1979) The loss of creatine phosphokinase (CK) from intramuscular injection sites in rabbits. A predictive tool for local toxicity. Acta Pharmacol Toxicol 44, 324-328
38. Svendsen O, Højelse F, Bagdon RE (1985) Tests for local toxicity of intramuscular drug preparations: comparison of in vivo and in vitro methods. Acta Pharmacol Toxicol 56, 183-190
39. Toutain PL, Laurentie M, Autefage A, Alvinene M (1988) Hydrocortisone secretion: production rate and pulse characterization by numerical deconvolution. Am J Physiol 255, E688-E695
40. Toutain PL, Lassourd V, Costes G, Alvinene M, Bret L, Lefebvre HP, Braun JP (1995) A non-invasive and quantitative method for the study of tissue injury caused by intramuscular injection of drugs in horses. J Vet Pharmacol Therap 18, 226-235
41. Uccelli V, Deleforge J, Boisrame B (1988) Pharmacocinétique et tolérance locale comparées de deux formulations d'oxytétracycline chez la vache. Recl Méd Vét Ec Alfort, 164, 939-943
42. Verlinde V, Mikaelian I, Laurentie M, Sanders P, Poul JM (1996) Biodisponibilité de la créatine kinase musculaire chez le mouton. Application à l'évaluation de la tolérance locale de formulations vétérinaires injectables. Vet Res 27, 133-146
43. Volfinger L, Lassourd V, Michaux JM, Braun JP, Toutain PL (1994) Kinetic evaluation of muscle damage during exercise by calculation of amount of creatine kinase released. Am J Physiol 266, R434-R441
44. Young DS, Bermes EW (1994) Specimen collection and processing; sources of biological variation. In Tietz Textbook of Clinical Chemistry, 2nd edition (CA Burtis, ER Ashwood, eds), WB Saunders Company, Philadelphia, 58-101